Artificial Intelligence in Medicine
Volume 48, Issue 2 , Pages 99-106 , February 2010

Gene- and evidence-based candidate gene selection for schizophrenia and gene feature analysis

  • Jingchun Sun

      Affiliations

    • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA
    • Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN, USA
    • ,
  • Leng Han

      Affiliations

    • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA
    • ,
  • Zhongming Zhao

      Affiliations

    • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA
    • Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN, USA
    • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
    • Corresponding Author InformationCorresponding author at: Vanderbilt University Medical Center, Department of Biomedical Informatics, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA. Tel.: +1 615 343 9158; fax: +1 615 936 8545.

Received 16 August 2008 ,Revised 7 July 2009 ,Accepted 20 July 2009.

References 

  1. Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev. 2001;21(8):1125–1141
  2. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry. 1999;56(2):162–168
  3. Riley B, Kendler KS. Molecular genetic studies of schizophrenia. Eur J Hum Genet. 2006;14(6):669–680
  4. Crow TJ. Molecular pathology of schizophrenia: more than one disease process?. Br Med J. 1980;280(6207):66–68
  5. McGrath J. Schizophrenia genesis: the origins of madness. Aust N Z J Psychiatr. 1997;31:894–895
  6. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet. 2003;33(Suppl.):228–237
  7. Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z. Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(7):1173–1181
  8. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158(10):1568–1578
  9. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40(7):827–834
  10. Li D, He L. Meta-analysis shows association between the tryptophan hydroxylase (TPH) gene and schizophrenia. Hum Genet. 2006;120(1):22–30
  11. Munafo MR, Thiselton DL, Clark TG, Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry. 2006;11(6):539–546
  12. Levinson DF. Meta-analysis in psychiatric genetics. Curr Psychiatry Rep. 2005;7(2):143–151
  13. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet. 2004;75(3):353–362
  14. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol Biochem. 2007;20(6):687–702
  15. Schulz KF, Grimes DA. Case-control studies: research in reverse. Lancet. 2002;359(9304):431–434
  16. Levin KA. Study design V Case-control studies. Evid Based Dent. 2003;7:83–84
  17. Aragon T. EpiTools: R package for epidemiologic data and graphics, Version 0.4-8, http://www.epitool.net; 2007 [accessed 20 March 2007].
  18. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron. 2006;52(1):139–153
  19. Tu Z, Wang L, Xu M, Zhou X, Chen T, Sun F. Further understanding human disease genes by comparing with housekeeping genes and other genes. BMC Genomics. 2006;7:31
  20. Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005;33:W741–W748
  21. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA. 2004;101(16):6062–6067
  22. Jiang C, Han L, Su B, Li WH, Zhao Z. Features and trend of loss of promoter-associated CpG islands in the human and mouse genomes. Mol Biol Evol. 2007;24(9):1991–2000
  23. Strausberg RL. The Cancer Genome Anatomy Project: new resources for reading the molecular signatures of cancer. J Pathol. 2001;195(1):31–40
  24. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005;10(5):434–449
  25. Toda M, Abi-Dargham A. Dopamine hypothesis of schizophrenia: making sense of it all. Curr Psychiatry Rep. 2007;9(4):329–336
  26. Lewis DA, Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat Med. 2006;12(9):1016–1022
  27. Ford JM, Krystal JH, Mathalon DH. Neural synchrony in schizophrenia: from networks to new treatments. Schizophr Bull. 2007;33(4):848–852
  28. Palha JA, Goodman AB. Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Res Rev. 2006;51(1):61–71
  29. Mackay-Sim A, Feron F, Eyles D, Burne T, McGrath J. Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol. 2004;59:351–380
  30. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z. The dystrobrevin-binding protein 1 gene: features and networks. Mol Psychiatry. 2008;14(1):18–29

PII: S0933-3657(09)00102-X

doi: 10.1016/j.artmed.2009.07.009

Artificial Intelligence in Medicine
Volume 48, Issue 2 , Pages 99-106 , February 2010

Article Tools

* Image Usage & Resolution